Literature DB >> 9466763

Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women.

K A Kacena1, S B Quinn, M R Howell, G E Madico, T C Quinn, C A Gaydos.   

Abstract

The accuracy of pooling urine samples for the detection of genital Chlamydia trachomatis infection by ligase chain reaction (LCR) was examined. A model was also developed to determine the number of samples to be pooled for optimal cost savings at various population prevalences. Estimated costs included technician time, laboratory consumables, and assay costs of testing pooled samples and retesting individual specimens from presumptive positive pools. Estimation of population prevalence based on the pooled LCR results was also applied. After individual urine specimens were processed, 568 specimens were pooled by 4 into 142 pools and another 520 specimens were pooled by 10 into 52 pools. For comparison, all 1,088 urine specimens were tested individually. The sample-to-cut-off ratio was lowered from 1.0 to 0.2 for pooled samples, after a pilot study which tested 148 samples pooled by 4 was conducted. The pooling algorithm was 100% (48 of 48) sensitive when samples were pooled by 4 and 98.4% (61 of 62) sensitive when samples were pooled by 10. Although 2.0% (2 of 99) of the negative pools of 4 and 7.1% (1 of 14) of the negative pools of 10 tested presumptive positive, all samples in these presumptive-positive pools were negative when retested individually, making the pooling algorithm 100% specific. In a population with 8% genital C. trachomatis prevalence, pooling by four would reduce costs by 39%. The model demonstrated that with a lower prevalence of 2%, pooling eight samples would reduce costs by 59%. Pooling urine samples for detection of C. trachomatis by LCR is sensitive, specific, and cost saving compared to testing individual samples.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466763      PMCID: PMC104564     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models.

Authors:  F Behets; S Bertozzi; M Kasali; M Kashamuka; L Atikala; C Brown; R W Ryder; T C Quinn
Journal:  AIDS       Date:  1990-08       Impact factor: 4.177

2.  Detection of Chlamydia trachomatis by the polymerase chain reaction in swabs and urine from men with non-gonococcal urethritis.

Authors:  H M Palmer; C B Gilroy; B J Thomas; P E Hay; C Gilchrist; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

3.  Ability of commercial ligase chain reaction and PCR assays to diagnose Chlamydia trachomatis infections in men by testing first-void urine.

Authors:  M A Chernesky; S Chong; D Jang; K Luinstra; J Sellors; J B Mahony
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.

Authors:  M Laga; A Manoka; M Kivuvu; B Malele; M Tuliza; N Nzila; J Goeman; F Behets; V Batter; M Alary
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

5.  Use of a urine enzyme immunoassay as a diagnostic tool for Chlamydia trachomatis urethritis in men.

Authors:  J R Schwebke; A M Clark; M B Pettinger; P Nsubga; W E Stamm
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

6.  Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.

Authors:  F A Plummer; J N Simonsen; D W Cameron; J O Ndinya-Achola; J K Kreiss; M N Gakinya; P Waiyaki; M Cheang; P Piot; A R Ronald
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

7.  Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine.

Authors:  H H Lee; M A Chernesky; J Schachter; J D Burczak; W W Andrews; S Muldoon; G Leckie; W E Stamm
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

8.  Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera.

Authors:  R L Kline; T A Brothers; R Brookmeyer; S Zeger; T C Quinn
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

9.  Comparison of polymerase chain reaction, monoclonal antibody based enzyme immunoassay, and cell culture for detection of Chlamydia trachomatis in genital specimens.

Authors:  C H Wu; M F Lee; S C Yin; D M Yang; S F Cheng
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

10.  Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay.

Authors:  G Jaschek; C A Gaydos; L E Welsh; T C Quinn
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

View more
  28 in total

1.  Pooling of urine specimens for detection of asymptomatic Chlamydia trachomatis infections by PCR in a low-prevalence population: cost-saving strategy for epidemiological studies and screening programs.

Authors:  S A Morré; C J Meijer; C Munk; S Krüger-Kjaer; J F Winther; H O Jørgensens; A J van Den Brule
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  The Use of Molecular Techniques for the Diagnosis and Epidemiologic Study of Sexually Transmitted Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

3.  Pooling cervical swabs and testing by ligase chain reaction are accurate and cost-saving strategies for diagnosis of Chlamydia trachomatis.

Authors:  J Kapala; D Copes; A Sproston; J Patel; D Jang; A Petrich; J Mahony; K Biers; M Chernesky
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

4.  Evaluation of laboratory testing methods for Chlamydia trachomatis infection in the era of nucleic acid amplification.

Authors:  T J Battle; M R Golden; K L Suchland; J M Counts; J P Hughes; W E Stamm; K K Holmes
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  Chlamydia trachomatis diagnostics.

Authors:  M A Chernesky
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

6.  Current Issues in Screening for Chlamydia trachomatis.

Authors:  Robert L. Cook; Lars ØStergaard
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

7.  Pooling of clinical specimens prior to testing for Chlamydia trachomatis by PCR is accurate and cost saving.

Authors:  Marian J Currie; Michelle McNiven; Tracey Yee; Ursula Schiemer; Francis J Bowden
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  A Population-Specific Optimized GeneXpert Pooling Algorithm for Chlamydia trachomatis and Neisseria gonorrhoeae To Reduce Cost of Molecular Sexually Transmitted Infection Screening in Resource-Limited Settings.

Authors:  Sarah Connolly; William Kilembe; Mubiana Inambao; Ana-Maria Visoiu; Tyronza Sharkey; Rachel Parker; Kristin M Wall; Amanda Tichacek; Eric Hunter; Susan Allen
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

9.  Utility of pooled urine specimens for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in men attending public sexually transmitted infection clinics in Mumbai, India, by PCR.

Authors:  Christina Lindan; Meenakshi Mathur; Sameer Kumta; Hermangi Jerajani; Alka Gogate; Julius Schachter; Jeanne Moncada
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

10.  Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay.

Authors:  L Dize; S K West; H Mkocha; T C Quinn; C A Gaydos
Journal:  Diagn Microbiol Infect Dis       Date:  2014-11-27       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.